Amongst the hematologic malignancies, MLL-rearranged acute leukemia, including MLL-rearranged acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), remain both a significant clinical problem and a pathogenetic enigma. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.